一种对胆固醇敏感的肝脏tRNA衍生小RNA调节胆固醇稳态和动脉样硬化发展
Xiuchun Li1, Rebecca Hernandez1, Xudong Zhang2,3
1Division of Biomedical Sciences, School of Medicine, University of California, Riverside, CA, USA.
Nature communications
|December 15, 2025
概括
转移RNA衍生的小RNAs (tsRNAs) 调节胆固醇. 这项研究确定了肝脏中的tsRNA-Glu-CTC,显示了它在高胆固醇血症,肝硬化和动脉样硬化中的作用,为心脏代谢疾病提供了新的治疗点.
科学领域:
- 分子生物学分子生物学
- 心血管生物学 心血管生物学
- 在RNA生物学,RNA生物学.
背景情况:
- 转移RNA衍生的小RNAs (tsRNAs) 越来越多地被认可为它们的生物作用.
- 在脂质代谢和心血管疾病中tsRNAs的特定功能尚不清楚.
研究的目的:
- 研究tsRNAs在脂质代谢和心血管疾病中的作用.
- 为了识别和描述参与胆固醇恒温的新型tsRNAs.
主要方法:
- 潘多拉-seq用于tsRNA识别.
- 在体内小鼠模型的高胆固醇血症,肝硬化和动脉样硬化.
- 用于RNA修饰分析的MLC-seq.
- 分子测试以评估基因调节.
主要成果:
- tsRNA-Glu-CTC被确定为老鼠肝脏中最丰富的tsRNA,并且对胆固醇有反应.
- 过度表达tsRNA-Glu-CTC导致高胆固醇血症和肝脏肥胖症.
- 阻断 tsRNA-Glu-CTC 保护其免受饮食引起的高胆固醇血症和动脉样硬化.
- tsRNA-Glu-CTC通过一个E-box动机直接调节SREBP2转录.
- 特定位点的RNA修改增强了tsRNA-Glu-CTC对胆固醇稳态的调节效能.
结论:
- 肝脏丰富的tsRNA,tsRNA-Glu-CTC,在调节脂质代谢方面发挥着重要作用.
- tsRNA-Glu-CTC 是高胆固醇血症和动脉样硬化的关键调解者.
- 这种tsRNA及其修改代表了心脏代谢疾病的潜在治疗点.
相关概念视频
01:29Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
01:45Regulation of Nuclear Protein Sorting
3.2K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.2K
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
01:29Translational Regulation
507
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
507
02:15Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
01:26Atherosclerosis III: Management
293
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293